Treatment of asthma and copd using triple-combination therapy

Details Treatment of asthma and copd using triple-combination therapy Treatment of asthma and copd using triple-combination therapy

A - Human Necessities

61

K

A61K 31/4704 (2006.01) A61K 31/40 (2006.01) A61K 31/58 (2006.01) A61P 11/00 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2628321

A medicament comprising, separately or together (A) a compound of formula (I) in free or salt or solvate form, wherein W, Rx, Ry, R1, R2, R3, R4, R5, R6 and R7 have the meanings as indicated in the specification; (B) a glycopyrronium salt; and (C) mometasone furoate; for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease.

La présente invention concerne un médicament comprenant, de manière séparée ou conjointe, (A) un composé de formule (I) sous une forme libre, sous une forme de sel ou sous une forme de solvate, dans laquelle W, Rx, Ry, R1, R2, R3, R4, R5, R6 et R7 ont les significations indiquées dans la description, (B) un sel de glycopyrronium et (C) du furoate de mométasone. Ce médicament est destiné à une administration simultanée, séquentielle ou séparée dans le cadre du traitement d'une maladie des voies respiratoires obstructive ou inflammatoire.

Affiliated with

Also associated with

Rating

Treatment of asthma and copd using triple-combination therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of asthma and copd using triple-combination therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of asthma and copd using triple-combination therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2019723